JP2011515406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011515406A5 JP2011515406A5 JP2011500890A JP2011500890A JP2011515406A5 JP 2011515406 A5 JP2011515406 A5 JP 2011515406A5 JP 2011500890 A JP2011500890 A JP 2011500890A JP 2011500890 A JP2011500890 A JP 2011500890A JP 2011515406 A5 JP2011515406 A5 JP 2011515406A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- following formula
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3762508P | 2008-03-18 | 2008-03-18 | |
| US61/037,625 | 2008-03-18 | ||
| US12/404,753 US7732443B2 (en) | 2008-03-18 | 2009-03-16 | Therapeutic substituted cyclopentanes |
| US12/404,753 | 2009-03-16 | ||
| PCT/US2009/037355 WO2009117388A1 (en) | 2008-03-18 | 2009-03-17 | Therapeutic substituted cyclopentanes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011515406A JP2011515406A (ja) | 2011-05-19 |
| JP2011515406A5 true JP2011515406A5 (enExample) | 2012-05-17 |
Family
ID=41089539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011500890A Pending JP2011515406A (ja) | 2008-03-18 | 2009-03-17 | 治療用の置換シクロペンタン類 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7732443B2 (enExample) |
| EP (1) | EP2265576A1 (enExample) |
| JP (1) | JP2011515406A (enExample) |
| KR (1) | KR20100135264A (enExample) |
| CN (1) | CN102007098B (enExample) |
| AU (1) | AU2009225706B2 (enExample) |
| BR (1) | BRPI0910931A2 (enExample) |
| CA (1) | CA2718900A1 (enExample) |
| RU (1) | RU2501789C2 (enExample) |
| WO (1) | WO2009117388A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8569349B2 (en) * | 2008-05-09 | 2013-10-29 | Allergan, Inc. | Therapeutic compounds |
| EP2303836A1 (en) * | 2008-05-09 | 2011-04-06 | Allergan, Inc. | Therapeutic cyclopentane derivatives |
| US9090595B2 (en) | 2012-08-27 | 2015-07-28 | Allergan, Inc. | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes |
| ES2711425T3 (es) * | 2012-08-27 | 2019-05-03 | Allergan Inc | Espesamiento de la córnea central reducido mediante el uso de profármacos de éster hidrófilos de beta-clorociclopentanos |
| KR20160124835A (ko) * | 2014-02-20 | 2016-10-28 | 알러간, 인코포레이티드 | 베타-클로로시클로펜탄의 친수성 에스테르 프로드럭의 사용에 의해 감소된 중앙 각막 비후 |
| US9340534B2 (en) * | 2014-07-25 | 2016-05-17 | Allergan, Inc. | Compounds and methods for treating ocular diseases |
| US10329284B2 (en) | 2014-10-02 | 2019-06-25 | Allergan, Inc. | Ester prodrugs of gamma-lactams and their use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) * | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4675182A (en) * | 1983-02-12 | 1987-06-23 | Bayer Aktiengesellschaft | Complexes of prostaglandins |
| US5462968A (en) * | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US5698598A (en) * | 1995-08-04 | 1997-12-16 | Allergan | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US6090847A (en) * | 1997-11-21 | 2000-07-18 | Allergan Sales, Inc. | EP2 -receptor agonists as neuroprotective agents for the eye |
| US6437146B1 (en) * | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| US6410591B1 (en) * | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| BR0213911A (pt) * | 2001-11-05 | 2004-09-28 | Allergan Inc | Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2 |
| KR101077461B1 (ko) * | 2003-02-11 | 2011-10-26 | 알러간, 인코포레이티드 | 안압 강하제로서의 10,10-디알킬 프로스탄산 유도체 |
| TWI348386B (en) * | 2003-08-12 | 2011-09-11 | R Tech Ueno Ltd | Composition and method for promoting hair growth |
| US7091231B2 (en) * | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| US7427685B2 (en) * | 2005-12-06 | 2008-09-23 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| WO2009137345A1 (en) * | 2008-05-09 | 2009-11-12 | Allergan, Inc. | Therapeutic compounds |
-
2009
- 2009-03-16 US US12/404,753 patent/US7732443B2/en not_active Expired - Fee Related
- 2009-03-17 JP JP2011500890A patent/JP2011515406A/ja active Pending
- 2009-03-17 CN CN200980113565.8A patent/CN102007098B/zh not_active Expired - Fee Related
- 2009-03-17 AU AU2009225706A patent/AU2009225706B2/en not_active Expired - Fee Related
- 2009-03-17 BR BRPI0910931A patent/BRPI0910931A2/pt not_active IP Right Cessation
- 2009-03-17 CA CA2718900A patent/CA2718900A1/en not_active Abandoned
- 2009-03-17 RU RU2010141793/04A patent/RU2501789C2/ru not_active IP Right Cessation
- 2009-03-17 KR KR1020107023241A patent/KR20100135264A/ko not_active Ceased
- 2009-03-17 WO PCT/US2009/037355 patent/WO2009117388A1/en not_active Ceased
- 2009-03-17 EP EP09723041A patent/EP2265576A1/en not_active Withdrawn